Clinical Trials Browser

Terminated × Lymphoma, Mantle-Cell × obinutuzumab × Clear all

NCT03311126 2024-10-24

Bendamustine + Obinutuzumab Induction With Obinutuzumab Maintenance in Untreated Mantle Cell Lymphoma

Phase 2 Terminated

21 enrolled 17 charts

Lymphoma, Non-Hodgkin, Lymphoma, Mantle-Cell

NCT03229382 2023-08-16

OPERA-PLRG10

Phase 2 Terminated

Lymphoma, Mantle-Cell